BMI: Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT01592058
Collaborator
(none)
427
1
23
18.6

Study Details

Study Description

Brief Summary

The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard).

The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    427 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
    Study Start Date :
    Jun 1, 2010
    Actual Primary Completion Date :
    May 1, 2012
    Actual Study Completion Date :
    May 1, 2012

    Outcome Measures

    Primary Outcome Measures

    1. Weight [Baseline and 12 months]

      Change in weight from baseline at 12 months.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients enrolled in CHOICE between the ages of 18 and 45 who consented to future studies

    • Chose levonorgestrel-releasing IUD, copper IUD, the implant, or DMPA as their CHOICE baseline method

    • Has baseline height and weight data collected from the on-campus enrollment site

    • Able to come back to the on-campus enrollment site for consent process and enrollment activities

    Exclusion Criteria:
    • Recent history of DMPA use before starting their baseline CHOICE method

    • Used current method for less than 11 months or more than 12 months and three weeks

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Washington University School of Medicine Saint Louis Missouri United States 63110

    Sponsors and Collaborators

    • Washington University School of Medicine

    Investigators

    • Principal Investigator: Tessa E Madden, MD, MPH, Washington University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Washington University School of Medicine
    ClinicalTrials.gov Identifier:
    NCT01592058
    Other Study ID Numbers:
    • 201102211
    First Posted:
    May 4, 2012
    Last Update Posted:
    Jul 31, 2012
    Last Verified:
    Jul 1, 2012
    Keywords provided by Washington University School of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 31, 2012